-
17-07-2015
GGGNNNIIIPPPSSSTTT BBBUUULLLLLLEEETTTIIINNN 22200011155517th
July, 2015 Volume No.: 47 Issue No.: 02
Vision
TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE
FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE
BASED LEARNING AND PRACTICE
Contents Message from PRINCIPAL Editorial board Historical
article News Update Knowledge based Article Disease Related
Breaking
News Upcoming Events Drugs Update Campus News Students Section
Editors Note Archive
GNIPST Photo Gallery For your comments/contribution OR For
Back-Issues, mailto:[email protected]
GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND
TECHNOLOGY
W e bs i t e : ht t p: / / gni ps t. a c. i n
-
17-07-2015
MESSAGE FROM PRINCIPAL
"It can happen. It does happen. But it can't happen if you
quit." Lauren Dane.
We are what we repeatedly do. Excellence then is not an act, but
a habit. Aristotle
It gives me immense pleasure to pen a few words for our
e-bulletin. At the onset I would like to thank the last years
editors and congratulate the newly selected editors for the current
year.
Our first consideration is always in the best interest of the
students. Our goal is to promote academic excellence and continuous
improvement.
I believe that excellence in education is aided by creating a
learning environment in which all learners are supported in
maximizing their potential and talents. Education needs to focus on
personalized learning and instruction, while promoting an education
system that is impartial, universally accessible, and meeting the
needs of all students.
It is of paramount importance that our learners have sufficient
motivation and encouragement in order to achieve their aims. We are
all very proud of you, our students, and your accomplishments and
look forward to watching as you put your mark on the profession in
the years ahead.
The call of the time is to progress, not merely to move ahead.
Our progressive Management is looking forward and wants our
Institute to flourish as a Post Graduate Institute of Excellence.
Steps are taken in this direction and fruits of these efforts will
be received by our students in the near future. Our Teachers are
committed and dedicated for the development of the institution by
imparting their knowledge and play the role of facilitator as well
as role model to our students.
The Pharmacy profession is thriving with a multitude of
possibilities, opportunities and positive challenges. At Guru Nanak
Institute of Pharmaceutical Science and Technology, our focus is on
holistic needs of our students.
I am confident that the students of GNIPST will recognize all
the possibilities, take full advantage of the opportunities and
meet the challenges with purpose and determination.
Excellence in Education is not a final destination, it is a
continuous walk. I welcome you to join us on this path.
My best wishes to all.
Dr. A. Sengupta
Click here to go at the top
1
-
17-07-2015
EDITORIAL BOARD
CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM
ASSOCIATE EDITOR MR. DIPANJAN MANDAL
HISTORICAL ARTICLE J. Willard Gibbs (1839 1903) Willard Gibbs
was a mathematical physicist who made enormous contributions to
science: he founded modern statistical mechanics, he founded
chemical thermodynamics, and he invented vector analysis. Early
Life and Education Josiah Willard Gibbs was born on February 11,
1839 in New Haven, Connecticut, USA, the hometown of Yale
University. Willard Gibbs family was prosperous and intellectual.
His mothers name was Mary Anna Van Cleve. She came from an eminent
family and was an amateur ornithologist. His fathers name was also
Josiah Willard Gibbs. To avoid confusion, Gibbs Jr. was always
known as Willard. His father, an expert on languages and
linguistics, was a professor of sacred literature at Yale
Universitys School of Divinity. Willard Gibbs was privately
educated at Hopkins Grammar School until he enrolled at Yale
University, aged just 15. He was awarded his degree four years
later, in 1858, along with university prizes in mathematics and
Latin. He immediately began working for an engineering Ph.D. at
Yale, which he was awarded in 1863, at the age of 24. This was the
first ever award of an engineering Ph.D. to any student at an
American university. His highly mathematical thesis had the title:
On the Forms of the Teeth of Wheels in Spur Gearing. Socially,
Gibbs was quiet and bookish, a somewhat reserved student.
Academically, he was brilliant.
Click here to go at the top
2
-
17-07-2015
While Gibbs was a student, three significant events took place:
In 1855, his mother died. In 1861, his father died, leaving Gibbs
and his two sisters a
substantial inheritance, making them financially independent.
From 186165 the American Civil War raged. Gibbs was not
conscripted: his health was fragile, and he suffered
fromrespiratory problems. Also, his eyesight for reading was
blurred,caused by astigmatism. He eventually had to grind lenses
himselfto solve this problem.Gibbs Academic CareerTutoring at
YaleYale University appointed Gibbs as a tutor in 1863. Tutors
wereexpected to make themselves available to teach any of
Yalescourses. Gibbs taught Latin for two years, followed by a
yearteaching physics, while he continued privately to widen
andsharpen his knowledge of engineering and the physical
sciences.During this time he patented an improved railway car
brake.Three Years in France and GermanyIn 1866 Gibbs and his
sisters, Anna and Julia, set off on a three-yeartrip to
Europe.Gibbs spent an academic year at each of the Sorbonne in
Paris, andthe Universities of Berlin and Heidelberg in Germany. His
single-minded purpose was to continue expanding and refining
hisscientific knowledge.Like his father, he seems to have had a
considerable gift forlanguages, so working in French and German
caused him noproblems.France, Germany and the United Kingdom lay at
the heart of thescientific world. Gibbs took a unique approach by
spending threeyears studying in the non-English speaking countries,
which gavehim a distinctive scientific viewpoint compared with
otherAmerican scientists of the time.During the trip to Europe,
Gibbs health was again a concern tuberculosis was suspected and he
and his sisters moved to theFrench Riviera, hoping the warm, dry
Mediterranean climate
Click here to go at the top
3
-
17-07-2015
would help him. Thankfully, after a few months on the Riviera,
he was pronounced free of tuberculosis. Professorship at Yale On
his return to New Haven, Gibbs taught French for a time at Yale,
and worked privately on some of his engineering ideas. In 1871 he
was appointed Yales first professor of mathematical physics. The
role was unpaid. Gibbs was happy with this situation he was a man
of modest needs, and his inheritance provided himwith more than
enough money. Furthermore, Gibbs was happy that the role required
little teaching work, allowing him more thinking and research time.
As his scientific reputation grew, other universities head-hunted
him. Gibbs chose to stay at Yale, because he was happy in the
familiar surroundings of his hometown and, also, Yales other
scientists told him how much they valued his presence at the
university. He stayed at Yale for the whole of his career and the
University started paying him a salary to counterbalance offers he
received from other institutions. Reshaping the Science of
Thermodynamics In 1878 Gibbs published a third thermodynamics
paper, the most revolutionary of them all. On the Equilibrium of
Heterogeneous Substances Part II. In this paper Gibbs founded the
science of chemical thermodynamics, entirely shaping our modern
understanding of the field. This work lies at the heart of physical
chemistry, telling us which chemical reactions are feasible.
Unfortunately, Gibbs work was so highly mathematical that it took
many years before its message was fully understood. If Gibbs had a
fault, it was that he used mathematics to do nearly all of his
talking for him. He felt little need to relate his mathematics and
ideas to real-world examples and he was not concerned if people
said his work was too hard to understand. Honors In 1880 Gibbs won
the Rumford Prize of the American Academy of Arts and Sciences.
Click here to go at the top
4
-
17-07-2015
In 1901 he was awarded the British Royal Societys Copely Medal,
which was then the greatest prize in science, equal to a Nobel
Prize today; and a rarer award, since only one Copely Medal was
awarded each year. The award citation stated that Gibbs was: the
first to apply the second law of thermodynamics to the exhaustive
discussion of the relation between chemical, electrical, and
thermal energy and capacity for external work. Some Personal
Details and the End Except for three years in Europe, Gibbs lived
all his life in the large family home his father built in New
Haven, Connecticut. This steady life suited him, because he was a
man who enjoyed regularity and order. There is an irony in this,
given that Gibbs significantly advanced our understanding of
entropy which is often characterized as disorder. He attended
church regularly and left New Haven only during his summer
vacations, which he liked to spend in the mountains. Gibbs was
perceived by people who knew him as kind, sympathetic and happy. He
never married. He shared the family home with his sisters: Anna,
who remained unmarried; and Julia, her husband and children. Josiah
Willard Gibbs died at the age of 64 on April 28, 1903, just a year
after he published his seminal work on statistical thermodynamics.
His death was caused by an intestinal obstruction. He was buried in
the Grove Street Cemetery, New Haven.
NEWS UPDATE New limb-lengthening technique is less
cumbersome for patients: 17th July, 2015 A highly specialized
procedure that lengthens bones can prevent the need for amputations
in selected patients who have suffered severe fractures. And now a
new study has found that an alternative limb-lengthening technique
makes the long recovery
Click here to go at the top
5
-
17-07-2015
process less cumbersome -- while still providing
good-to-excellent outcomes.
Can cholesterol-lowering drugs help treat acute Ebola cases? :
17th July, 2015 In the course of basic research in membrane
biochemistry scientists have gained new insight into the cytotoxic
effect of the Ebola virus. Employing biochemical and cell
biological methods they have shed light on the molecular
relationships between the Ebola glycoprotein and its role in
mediating cytotoxicity. Researchers discovered that the virus
glycoprotein interacts with cellular cholesterol, thus prompting
the use of certain cholesterol-lowering agents in their
investigations. The researchers report they succeeded in
suppressing cellular damage in cell cultures.
Researchers test bioartificial liver device to treat acute liver
failure: 17th July, 2015 Researchers have developed and are testing
an alternative to liver transplantation called the Spheroid
Reservoir Bioartificial Liver that can support healing and
regeneration of the injured liver, and improve outcomes and reduce
mortality rates for patients with acute liver failure.
Dairy products boost effectiveness of probiotics: 17th July,
2015 The success of probiotics for boosting human health may depend
partly upon the food, beverage, or other material carrying the
probiotics, according to research.
Cholesterol metabolism in immune cells linked to HIV
progression: 17th July, 2015 Lower levels of cholesterol in certain
immune cells -- a result of enhanced cholesterol metabolism within
those cells -- may help explain why some HIV-infected people are
able to naturally control disease progression, according to
research. The findings provide a basis for potential development of
new approaches to
Click here to go at the top
6
-
17-07-2015
control HIV infection by regulating cellular cholesterol
metabolism.
Lymphomas tied to metabolic disruption: 17th July, 2015 Direct
links between disrupted metabolism and an often fatal type of
lymphoma have been uncovered by researchers.
Study in mice may identify new ways to treat immune
thrombocytopenia: 17th July, 2015 A study in mice may identify new
ways to treat immune thrombocytopenia. Immune thrombocytopenia, or
ITP, is an autoimmune disease whereby the immune system sends
antibodies to attack and destroy the body's platelets--blood cells
responsible for controlling bleeding.
Moderate hormone suppression may be enough in thyroid cancer,
30-year study shows: 17th July, 2015 Moderate suppression of
thyroid-stimulating hormone, which drives thyroid cancer, may be as
beneficial as more extreme hormone suppression, a study of
long-term thyroid cancer outcomes shows. Extreme TSH suppression is
associated with increased side effects including osteoporosis and
heart rhythm irregularities.
Personalized care for aortic aneurysms, based on gene testing,
has arrived: 16th July, 2015 Researchers have tested the genomes of
more than 100 patients with thoracic aortic aneurysms, a
potentially lethal condition, and provided genetically personalized
care. Their work will also lead to the development of a
'dictionary' of genes specific to the disease, according to
researchers.
Click here to go at the top
7
-
17-07-2015
Emissions have declined, but sulfur dioxide air pollutant still
a concern for asthmatics: 16th July, 2015 Emissions of the air
pollutant sulfur dioxide have been dramatically decreased during
the past 30 years but for some people even a little inhaled sulfur
dioxide may still be too much. For detail mail to editor
KNOWLEDGE BASED ARTICLE Miniature brains made from patient skin
cells
reveal insights into autism Understanding diseases like autism
and schizophrenia that affect development of the brain has been
challenging due to both the complexity of the diseases and the
difficulty of studying developmental processes in human tissues. In
a study published July 16 in Cell, researchers have made steps
toward overcoming these challenges by converting skin cells from
autism patients into stem cells and growing them into tiny brains
in a dish, revealing unexpected mechanisms of the disease. Most
autism research has taken the approach of combing through patient
genomes for mutations that may underlie the disorder and then using
animal or cell-based models to study the genes and their possible
roles in brain development. Although this has yielded a handful of
rare disease genes, the limitations of these models and the
complexity of the disorder have frustrated researchers and left
over 80% of autism cases with no clear genetic cause. The new study
now turns the traditional approach on its head. "Instead of
starting from genetics, we've started with the biology of the
disorder itself to try to get a window into the genome," says
senior author Flora Vaccarino the Harris Professor of Child
Psychiatry and Professor or Neurobiology at the Yale School of
Medicine.
Click here to go at the top
8
-
17-07-2015
The clinical characteristics of autism are complex and
wide-ranging, making the prospect of finding common underlying
factors slim. To stack the deck in their favor, the researchers
focused on the approximately one-fifth of autism patients that
share a distinctive feature correlated with disease severity--an
enlarged brain. After isolating skin cells from these individuals,
as well as their unaffected fathers to provide a point of
comparison, the researchers converted the cells into induced
pluripotent stem cells that were then grown into miniature brains.
These so-called "brain organoids" are just a few millimeters in
diameter but mimic the basics of early human brain development,
roughly corresponding to the first few months of gestation. When
the researchers analyzed the patient organoids, they uncovered
altered expression networks for genes controlling neuronal
development. Patient organoids showed an unexpected overproduction
of inhibitory neurons that quiet down neural activity, while those
that excite the partners they're wired to were unaffected, leading
to an imbalance in neuron type. Remarkably, by suppressing the
expression of a single gene whose expression was abnormally
increased in patient organoids, the authors were able to correct
this bias, suggesting that it may be possible to intervene
clinically to restore neuronal balance. With current technology,
human brain organoids only recapitulate early stages of
development; however, efforts to extend their growth to later
stages are under way by a number of groups and will allow even
further insights into disease mechanisms. The authors are now using
their data to home in on the difficult-to-find mutations or
epigenetic changes responsible for the gene expression alterations
and neuronal imbalance observed in the study. According to
Vaccarino: "This study speaks to the importance of using human
cells and using them in an assay that could bring a better
understanding of the pathophysiology of autism and with that,
possibly better treatments." The success of the approach also
suggests that similar methods might be used to gain important
Click here to go at the top
9
-
17-07-2015
insights into other human developmental diseases that have until
now been difficult to crack open. This work was primarily supported
by the National Institutes of Health, the Harris Professorship
fund, The National Institute of Mental Health, the State of
Connecticut, and the Foster-Davis Foundation Inc. through the Brain
and Behavior Research Foundation.
Jeenatara Begum Assistant Professor
GNIPST
DISEASE RELATED BREAKING NEWS Middle East respiratory syndrome
coronavirus
(MERS-CoV) Republic of Korea : 17th July, 2015 Situation in the
Republic of Korea Between 15 and 17 July 2015, the National IHR
Focal Point of the Republic of Korea notified WHO of no additional
cases of infection and no new deaths related to Middle East
Respiratory Syndrome Coronavirus (MERS-CoV). Read more
UPCOMING EVENTS 61st IPSF World Congress sponsored by Indian
Pharmaceutical
Association (IPA) at Marriott Hotel, Hyderabad, India is going
to on 30th July to 9th August, 2015.
For further details please visit www.ipsf2015.org
Click here to go at the top
10
-
17-07-2015
DRUGS UPDATES Ipsen Announces FDA Approval of Dysport
(abobotulinumtoxinA) for Upper Limb Spasticity: 16th July, 2015
Ipsen (Euronext: IPN; ADR: IPSEY) announced that the U.S. Food and
Drug Administration (FDA) has approved its supplemental Biologics
License Application (sBLA) for Dysport (abobotulinumtoxinA) for the
treatment of upper limb spasticity in adult patients after the
submission of the dossier in September 2014. Dysport is now
approved for the treatment of upper limb spasticity in adult
patients, to decrease the severity of increased muscle tone in
elbow flexors, wrist flexors and finger flexors. Clinical
improvement may be expected one week after administration of
Dysport. A majority of patients in clinical studies were retreated
between 12 and 16 weeks; some patients had a duration of response
as long as 20 weeks. In Europe, regulatory procedures are in
progress for strengthening the existing upper limb spasticity label
indication of Dysport to include key medical data such as muscle
dose recommendations, treatment intervals, efficacy data and safety
updates. Read more
CAMPUS NEWSFAREWELL PROGRAMME:
On 15th May 2015 GNIPST clebrated the farewell programme Sesh
Chithi for the final year students of M.Pharm, M.Sc, B.Pharm, B.Sc
and BHM.
JIS SAMMAN 2015 On 11th May, 2015 GNIPST attended the JIS SAMMAN
2015.
JIS SAMMAN Awards: Best College (Non Engineering):
GNIPST Best Principal:
Click here to go at the top
11
-
17-07-2015
Dr (Prof.) Avijit Sengupta Best HOD:
Mr. Jaydip Ray Best Faculty:
Mr. Debabrata Ghoshdastidar (Pharmacy)Dr. Swati Chakraborty
(Life Sciences)
Best faculty since inception:Mr. Jaydip Ray
Best Office Staff:Ms. Jaya Banerjee
Best technical Assistant:Mr. Somnath Majhi
College Blue:Avik Paul
Highest DGPA of 2014:B.Pharm:
Purbali Chakraborty (4th year) Diksha Kumari (3rd year) Aishika
Dutta (2nd year) Sampita Paul (1st year) M.Pharm: Aritra Mukherjee
(Pharmaceutical Chemistry) Mounomukhar Bhattacharya (Pharmacology)
B.Sc (Biotechnology): Papiya Saha (3rd year) Shomasree Das (2nd
year) Ayanita Basak (1st year) B.Sc (Microbiology): Bonhisikha
Chatterjee (3rd year) Riaz Hossain (2nd year) Soumi Chowdhury (1st
year) BHM: Bishal Roy (3rd year) Shreyabhanja Chowdhury (2nd
year)
Click here to go at the top
12
-
17-07-2015
Recitation: Udita Majumder Debate:
Srijita Roy Poushali Ganguly Quiz:
Arani Ray Dipayan Nath Band:
Syantan Ghoswami Anurag Ghosh Atanu Mondal Arka Khamaru
Ritobroto Paul Abhirup Dasgupta
Fashion: Md. Nadeem Shah Koustav Sarkar Shaksar Saha Avirup
Dasgupta Ranit Kundu Namrata Ganguly Shreyasee Mitra Chandrika Saha
Debopriya Chatterjee Riya Taran
Innovative Modeling: Ankit Chowdhury Kartik Koley Mudasar Manna
Dipan Chaterjee Abhishek Singh Kaustav Pal Manojit Dutta
Click here to go at the top
13
-
17-07-2015
SPIRIT JIS 2015 On 03th to 05th April, 2015 JIS organised SPIRIT
JIS 2015. GPAT 2015 Result:
The following B.Pharm. final year students have qualified,
GPAT-2015. We congratulate them all. Diksha Kumari Rupanjay
Bhattacharya Avik Paul Xtasy 2015: GNIPST is going to organize the
Tech Fest Xtasy 2015 from 30th March, 2015 to 1st April, 2015.
FINISHING SCHOOL TRAINING PROGRAMME: The FINISHING SCHOOL
TRAINING PROGRAMME is going to organize by the Entrepreneurship
Development Cell and Training & Placement Cell, GNIPST in
collaboration with Indian Pharmacy Graduates Association (IPGA),
Bengal Branch from 21st February to 11th April, 2015 at GNIPST
Auditorium. On 21
st February, 2015 the Finishing School Training Programme of
GNIPST was inaugurated by Sri Soumen Mukhopadhyay, Deputy
Director, Drug Control Office, Goutam Kr. Sen, President, IPGA, Mr.
Subroto Saha, Asst. Directorate, Drug Control Office, Mr. Ranendra
Chakraborty, Sales Manager and Associate Director Dr. Reddys
Laboratory. On 28th February, 2015 Dr. D. Roy, Former Deputy Drug
Controller, Mr. Sujoy Chakraborty, divisional Therapy Manager,
Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning &
Development, Cipla delivered their valuable lectures in the 2nd day
FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 14th March, 2015
Mr. Milindra Bhattacharya, Senior Manager, QA & QC, Emami Ltd.
and Mr. Joydev Bhoumik, Manager, Operation, Ranbaxy Laboratory
Limited delivered their valuable lectures in the 3rd day FINISHING
SCHOOL TRAINING PROGRAMME of GNIPST.
Click here to go at the top
14
-
17-07-2015
On 21st March, 2015 Mr. Tridib Neogi, Associate Vice-President
(Quality Assurance), Albert David Ltd. delivered his valuable
lectures in the 4th FINISHING SCHOOL TRAINING PROGRAMME of GNIPST.
On 28th March, 2015 Dr. Gautam Chaterjee, an Alumni of Jadavpur
University and presently associated with NIPER delivered his
valuable lectures in the 5th FINISHING SCHOOL TRAINING PROGRAMME of
GNIPST. On 11th April, 2015 the closing ceremony of the FINISHING
SCHOOL TRAINING PROGRAMME was held in GNIPST Auditorium.
JOBS: All the students of Final Year B. Pharm and M. Pharm are
hereby informed that an interview will be conducted on 23rd May,
2015 by Standard Pharmaceuticals Ltd. GSK for post: Production, QA,
QC. All the students of Final Year B. Pharm and M. Pharm are hereby
informed that an interview will be conducted by GSK for sales and
marketing job. Details given below:
Date: 27.03.2015Time: 09:45 amVenue : GSK Consumer Healthcare
Limited, Unit No. 208,
2nd Floor, Ecospace Campus B (3 B), New Town, Rajarhat, 24 Pgs
(N). Kolkata-700156.
THYROCARE provisionally selected 15 students from JIS Group.
Amongst these, 3 students of B. Sc (H) Biotechnology and M. Sc
Biotechnology have been selected. Ipsita Mondal (M. Sc
Biotechnology)Debriti Paul (M. Sc Biotechnology)Debopriya
Chatterjee {B. Sc (H) Biotechnology}
The final year students of B.Pharm (31 students) and B.Sc (11
students) attended the pooled campus drive of Abbott India Ltd. on
10th March, 2015 at Jadavpur University. Among them 17 students
have gone through to the final round of this pooled campus drive
and short listed for final selection.
Click here to go at the top
15
-
17-07-2015
ACHIEVEMENT: Congratulations to Anurag Chanda, student of
B.Pharm final year
who have got the 1st prize in poster presentation event in
Prakriti 2015 at Department of Agricultural and Food engineering,
IIT, Kharagpur.
OTHERS: On 24th and 25th February, 2015 Swamiji of Gourio
Mathwasdelivered some motivational lectuers in GNIPST.
The students of GNIPST participated in the 4th Sardar
JodhSinghTrophy organised by NIT on 20th February, 2015. On 8th
February, 2015 Gnipst celebrated the ReunionprogrammeReminiscence
Reloaded 2015.
STUDENTS SECTION WHO CAN ANSWER FIRST????
Peru,oya and Kuroshio are types ofwhich geographical
phenomenon?
Answer of Previous Issues Questions: Dopamin
Identify the person
Answer of Previous Issues Image: Lewis Carroll
Click here to go at the top
16
-
17-07-2015
Send your thoughts/Quiz/Puzzles/games/write-ups or any other
contributions for Students Section& answers of this Section at
[email protected] NOTE
It is a great pleasure for me to publish the 2nd issue of 47th
Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN are
able to avail the bulletin through facebook account GNIPST bulletin
I am very much thankful to all the GNIPST members and readers who
are giving their valuable comments, encouragements and supports. I
am also thankful to Dr. Abhijit Sengupta, Director of GNIPST for
his valuable advice and encouragement. Special thanks to Dr.
Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya
Bhattacharya for their kind co-operation and technical supports.
Thank you Mr. Soumya Bhattacharya for the questionnaires of the
student section. An important part of the improvement of the
bulletin is the contribution of the readers. You are invited to
send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.
ARCHIVE The general body meeting of APTI, Bengal Branch has
been
conducted at GNIPST on 15th June, 2012. The program started
witha nice presentation by Dr. Pulok Kr. Mukherjee, School of
NaturalProducts, JU on the skill to write a good manuscript
forpublication in impact journals. It was followed by nearly two
hourlong discussion among more than thirty participants on
differentaspects of pharmacy education. Five nonmember
participantsapplied for membership on that very day.
Click here to go at the top
17
-
17-07-2015
GNIPST is now approved by AICTE and affiliated to WBUT
forconducting the two years post graduate course (M.Pharm)in
PHARMACOLOGY. The approved number of seat is 18.
The number of seats in B.Pharm. has been increased from 60
to120.
AICTE has sanctioned a release of grant under ResearchPromotion
Scheme (RPS) during the financial year 2012-13toGNIPST as per the
details below:a. Beneficiary Institution: Guru Nanak Institution of
PharmaceuticalScience & Technology.
b. Principal Investigator: Dr. LopamudraDutta.c. Grant-in-aid
sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 yearse. Title of the project: Screening
and identification of potential
medicinal plant of Purulia & Bankura districts of West
Bengal with respect to diseases such as diabetes, rheumatism,
Jaundice, hypertension and developing biotechnological tools for
enhancing bioactive molecules in these plants.
Activity Clubs of GNIPST: Name of Club Member Faculty SPORTS Mr.
Debabrata GhoshDastidar LITERARY AND PAINTING Ms. Jeenatara Begum
SCIENCE AND INNOVATIVE MODELLING
Mr. Samrat Bose
ECO Ms. Sumana Roy SOCIAL SERVICES Dr. Asis Bala PHOTOGRAPHY Ms.
Sanchari Bhattacharya CULTURAL Ms. Priyanka Ray DEBATE AND
EXTEMPORE Mr. Soumya Bhattacharya
Click here to go at the top
18
J. Willard Gibbs (1839 1903)Willard Gibbs was a mathematical
physicist who made enormous contributions to science: he founded
modern statistical mechanics, he founded chemical thermodynamics,
and he invented vector analysis.Early Life and EducationGibbs
Academic Career
Gibbs spent an academic year at each of the Sorbonne in Paris,
and the Universities of Berlin and Heidelberg in Germany. His
single-minded purpose was to continue expanding and refining his
scientific knowledge.Reshaping the Science of
ThermodynamicsHonorsSome Personal Details and the End
New limb-lengthening technique is less cumbersome for patients:
17th July, 2015A highly specialized procedure that lengthens bones
can prevent the need for amputations in selected patients who have
suffered severe fractures. And now a new study has found that an
alternative limb-lengthening technique makes the long recovery
proc... Can cholesterol-lowering drugs help treat acute Ebola
cases? : 17th July, 2015In the course of basic research in membrane
biochemistry scientists have gained new insight into the cytotoxic
effect of the Ebola virus. Employing biochemical and cell
biological methods they have shed light on the molecular
relationships between the... Researchers test bioartificial liver
device to treat acute liver failure: 17th July, 2015Researchers
have developed and are testing an alternative to liver
transplantation called the Spheroid Reservoir Bioartificial Liver
that can support healing and regeneration of the injured liver, and
improve outcomes and reduce mortality rates for pa... Dairy
products boost effectiveness of probiotics: 17th July, 2015The
success of probiotics for boosting human health may depend partly
upon the food, beverage, or other material carrying the probiotics,
according to research. Cholesterol metabolism in immune cells
linked to HIV progression: 17th July, 2015Lower levels of
cholesterol in certain immune cells -- a result of enhanced
cholesterol metabolism within those cells -- may help explain why
some HIV-infected people are able to naturally control disease
progression, according to research. The findin... Lymphomas tied to
metabolic disruption: 17th July, 2015Direct links between disrupted
metabolism and an often fatal type of lymphoma have been uncovered
by researchers. Study in mice may identify new ways to treat immune
thrombocytopenia: 17th July, 2015A study in mice may identify new
ways to treat immune thrombocytopenia. Immune thrombocytopenia, or
ITP, is an autoimmune disease whereby the immune system sends
antibodies to attack and destroy the body's platelets--blood cells
responsible for contro... Moderate hormone suppression may be
enough in thyroid cancer, 30-year study shows: 17th July,
2015Moderate suppression of thyroid-stimulating hormone, which
drives thyroid cancer, may be as beneficial as more extreme hormone
suppression, a study of long-term thyroid cancer outcomes shows.
Extreme TSH suppression is associated with increased side e...
Personalized care for aortic aneurysms, based on gene testing, has
arrived: 16th July, 2015Researchers have tested the genomes of more
than 100 patients with thoracic aortic aneurysms, a potentially
lethal condition, and provided genetically personalized care. Their
work will also lead to the development of a 'dictionary' of genes
specific ... Emissions have declined, but sulfur dioxide air
pollutant still a concern for asthmatics: 16th July, 2015Emissions
of the air pollutant sulfur dioxide have been dramatically
decreased during the past 30 years but for some people even a
little inhaled sulfur dioxide may still be too much.For detail mail
to editor
KNOWLEDGE BASED ARTICLEMiniature brains made from patient skin
cells reveal insights into autism Middle East respiratory syndrome
coronavirus (MERS-CoV) Republic of Korea : 17th July, 2015Situation
in the Republic of Korea
Read more Ipsen Announces FDA Approval of Dysport
(abobotulinumtoxinA) for Upper Limb Spasticity: 16th July,
2015Ipsen (Euronext: IPN; ADR: IPSEY) announced that the U.S. Food
and Drug Administration (FDA) has approved its supplemental
Biologics License Application (sBLA) for Dysport
(abobotulinumtoxinA) for the treatment of upper limb spasticity in
adult patien... CAMPUS NEWS STUDENTS SECTION